Advertisement

U.S. Markets closed

S&P Futures
5,913.00
+7.00(+0.12%)
Dow Futures
43,571.00
+53.00(+0.12%)
Nasdaq Futures
20,515.75
+32.25(+0.16%)
Russell 2000 Futures
2,296.50
+5.30(+0.23%)
Crude Oil
69.32
+0.10(+0.14%)
Gold
2,740.90
+10.90(+0.40%)

Telix Pharmaceuticals Limited (TLPPF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD

14.80

+0.01

(+0.07%)

At close: 04:00PM EDT

Loading interactive chart...

PR Newswire
Telix Files Form 20-F Registration Statement for Nasdaq ADS
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces that it has publicly filed a Form 20-F registration statement (Registration Statement) with the United States (U.S.) Securities and Exchange Commission (SEC) relating to a proposed listing of American Depository Shares (ADS), representing the Company's ordinary shares, on the Nasdaq Stock Market (Nasdaq).
PR Newswire
Telix Q3 2024 Business Update - Quarterly Revenue Exceeds AU$200M
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an update on its revenue and operational performance for the quarter ended 30 September 2024 (Q3 2024).